Status:
UNKNOWN
Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic
Lead Sponsor:
Max Healthcare Insititute Limited
Conditions:
Oncology Patients
Eligibility:
All Genders
12-98 years
Brief Summary
In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been design...
Detailed Description
Protocol No: Onco\_Covid-19 Version no:1.0 Objectives: Firstly the patients recently diagnosed with cancer will be selected for enrollment who are on active treatment during lockdown based on the da...
Eligibility Criteria
Inclusion
- Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020
- Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020
Exclusion
- \-
Key Trial Info
Start Date :
May 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04406844
Start Date
May 9 2020
End Date
June 30 2021
Last Update
July 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Max Superspeciality hospital, A Unit of Balaji Medical and Diagnostic Centre
New Delhi, India, 110092